| [1] |
GBD Obesity Collaborators, Afshin A, Forouzanfar M H, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years[J]. New England Journal of Medicine, 2017, 377(1): 13-27.
|
| [2] |
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes[J]. New England Journal of Medicine, 2017, 376(7): 641-651.
|
| [3] |
Schauer PR, Nor Hanipah Z, Rubino F. Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world’s leading diabetes organizations[J]. Clevel Clin J Med, 2017, 84 (Suppl. 1): S47-S56.
|
| [4] |
Reges O, Greenland P, Dicker D, et al. Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality[J]. Jama, 2018, 319(3): 279-290.
|
| [5] |
Chen R, Snyder M. Promise of personalized omics to precision medicine[J]. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2013, 5(1): 73-82.
|
| [6] |
Ahmad A, Catherine T, Ali T, et al. Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management[J]. Nutrients, 2017, 9(12):1310.
|
| [7] |
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis.[J] Am. J. Med. 2009, 122(3): 248-256.
|
| [8] |
Nicoletti CF, deOliveira BA, dePinhel MA, et al. Influence of excess weight loss and weight regain on biochemical indicators during a 4-year follow-up after Roux-en-Y gastric bypass[J]. Obes. Surg. 2015, 25(2): 279-284.
|
| [9] |
Ping L, Yu H, Zhao X, et al. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography–Mass Spectrometry[J]. Journal of Proteome Research, 2016, 15(4):1288-1299.
|
| [10] |
Zhao L, Ni Y, Yu H, et al. Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity[J]. Faseb Journal Official Publication of the Federation of American Societies for Experimental Biology, 2017, 31(4):1449-1460.
|
| [11] |
Kwon HN, Lee YJ, Kang JH, et al. Prediction of glycated hemoglobin levels at 3 months after metabolic surgery based on the 7-day plasma metabolic profile[J]. Plos One, 2014, 9(11): e109609.
|
| [12] |
Velázquez-Fernández D, Mercado-Celis G, Flores-Morales J, et al. Analysis of Gene Candidate SNP and Ancestral Origin Associated to Obesity and Postoperative Weight Loss in a Cohort of Obese Patients Undergoing RYGB[J]. Obes Surg, 2017, 27(6):1481-1492
|
| [13] |
Vitolo E, Santini E, Seghieri M, et al. Heterozygosity for the rs696217 SNP in the Preproghrelin Gene Predicts Weight Loss After Bariatric Surgery in Severely Obese Individuals[J]. Obesity Surgery, 2017, 27(4): 1-7.
|
| [14] |
Hartmann IB, Fries GR, Bucker J, et al. The FKBP5 polymorphism rs1360780 is associated with lower weight loss after bariatric surgery: 26 months of follow-up[J]. Surgery for Obesity & Related Diseases, 2016, 12(8): 1554-1560.
|
| [15] |
Bandstein M, Mwinyi J, Ernst B, et al. A genetic variant in proximity to the gene LYPLAL1 is associated with lower hunger feelings and increased weight loss following Roux-en-Y gastric bypass surgery[J]. Scand J Gastroenterol, 2016, 51(9): 1050-1055.
|
| [16] |
Nicoletti CF, de Oliveira AP, Brochado MJ, et al. UCP1-3826 A>G polymorphism affects weight, fat mass, and risk of type 2 diabetes mellitus in grade III obese patients[J].Nutrition, 2016, 32(1): 83-87.
|
| [17] |
Rasmussentorvik LJ, Baldridge AS, Pacheco JA, et al. rs4771122 predicts multiple measures of long-term weight loss after bariatric surgery[J]. Obesity Surgery, 2015, 25(11): 2225-2229.
|
| [18] |
Valette M, Poitou C, Le Beyec J, et al. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery[J]. PLoS One, 2012, 7(11): e48221.
|
| [19] |
Sarzynski MA, Jacobson P, Rankinen T, et al. Changes in uric acid levels following bariatric surgery are not associated with SLC2A9 variants in the Swedish Obese Subjects Study[J]. PLoS One, 2012, 7(12): e51658.
|
| [20] |
Modesitt SC, Hallowell PT, Slack-Davis JK, et al. Women at extreme risk for obesity-related carcinogenesis: Baseline endometrial pathology and impact of bariatric surgery on weight, metabolic profiles and quality of life[J]. Gynecologic Oncology, 2015, 138(2): 238-245.
|
| [21] |
Rodríguezgallego E, Guirro M, Rieraborrull M, et al. Mapping of the circulating metabolome revealsα-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease[J]. International Journal of Obesity, 2015, 39(2): 279-287.
|
| [22] |
Mutch DM, Fuhrmann JC, Rein D, et al. Metabolite Profiling Identifies Candidate Markers Reflecting the Clinical Adaptations Associated with Roux-en-Y Gastric Bypass Surgery[J]. Plos One, 2009, 4(11): e7905.
|
| [23] |
Thiago I.B. Lopes, Bruno Geloneze, JoséC. Pareja. "Omics" Prospective Monitoring of Bariatric Surgery: Roux-En-Y Gastric Bypass Outcomes Using Mixed-Meal Tolerance Test and Time-Resolved 1H NMR-Based Metabolomics[J]. Omics A Journal of Integrative Biology, 2016, 20(7): 415-423.
|
| [24] |
Deng ZB, Poliakov A, Hardy RW, et al. Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance[J]. Diabetes, 2009, 58(11): 2498-2505.
|
| [25] |
Hubal MJ, Nadler EP, Ferrante SC, et al. Circulating adipocyte‐derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypass[J]. Obesity, 2016, 25(1): 102-110.
|
| [26] |
Freudenberg JM, Rajpal N, Way JM, et al. Gastrointestinal weight-loss surgery: glimpses at the molecular level [J]. Drug Discovery Today, 2013, 18(13-14): 625-636.
|
| [27] |
Tulipani S, Griffin J, Palau-Rodriguez M, et al. Metabolomics-guided insights on bariatric surgery versus behavioral interventions for weight loss[J]. Obesity, 2016, 24(12): 2451-2466.
|
| [28] |
Ewa G, Claudio L, Leonardo T, et al. Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner[J]. American Journal of Clinical Nutrition, 2015, 102(6): 1313-1322.
|
| [29] |
Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention[J]. Nature Medicine, 2017, 23(7): 859-868.
|
| [30] |
Jung J, Ha TK, Lee J, et al. Changes in one-carbon metabolism after duodenal-jejunal bypass surgery[J]. American Journal of Physiology Endocrinology & Metabolism, 2016, 310 (8): E624-E632.
|